Moheb Nasr, PhD, FAAPS

Nasr Pharma Regulatory Consulting, Washington, DC

Moheb Nasr

Moheb Nasr is the principal of his own consulting company, Nasr Pharma Regulatory Consulting (NPRC). NPRC was established in February 2018 and provides regulatory consulting with focus on pharmaceutical manufacturing innovation and CMC regulatory strategy. Dr. Nasr serves as a senior regulatory advisor for several chemical and biopharmaceutical companies in the US, Europe, and Asia. In addition, Dr. Nasr continues to play a leading role in global regulatory harmonization and introduction of modern pharmaceutical manufacturing platforms, including continuous manufacturing.

In August 2017 Dr. Nasr retired from GSK, where he was responsible for the development and execution of GSK global CMC regulatory strategy. In recognition of his scientific and regulatory contributions, Dr. Nasr is an elected GSK Senior Research Fellow. Prior to joining GSK, he spent over 22 years at US FDA, where he was the head of FDA/CDER CMC regulatory office. Dr. Nasr represented FDA and PhRMA at ICH and was instrumental in the development of the Quality by Design (QbD) concept and several regulatory ICH guidelines.

Dr. Nasr obtained his pharmacy and MS degrees at the University of Cairo, Egypt, and his PhD in chemistry at the University of Minnesota in Minneapolis. Dr. Nasr is an elected Fellow of the American Association of Pharmaceutical Scientists (AAPS) and the recipient of AAPS Regulatory Science Achievement Award and numerous academic and US Government awards.